Dansk
Nederlands
English
Suomi
Français
Deutsch
Ελληνικά
Italiano
Norsk
Polski
Português
Español
Svenska
Tesamorelin
€ 64,95
Don't forget the reconstitution water
Required for dissolving freeze-dried peptides.
All products are intended for laboratory research only and are not suitable for human or animal consumption. By purchasing, the buyer agrees to use these products in accordance with all applicable laws.
This substance has not been evaluated or approved by the European (EMA), American (FDA) or Dutch (MEB/IGJ) medicines authorities for any human or veterinary use. No medical, therapeutic, diagnostic or preventive use is claimed or implied.
Tesamorelin is a synthetic analogue of growth hormone-releasing hormone (GHRH), a peptide that is extensively studied in molecular, biochemical and endocrine research. It is designed to bind to GHRH receptors and plays a role in signaling pathways related to growth hormone regulation and cellular communication.
Due to its specific structure and receptor selectivity, Tesamorelin is often used in experimental models that focus on endocrine interactions, molecular signal transduction, and regulation of biological pathways.
History of Tesamorelin
Tesamorelin was developed within research on modified GHRH analogues with the aim of improving stability and receptor binding. Early studies focused on the activation of growth hormone-related signaling pathways, while later studies expanded to metabolic regulation, endocrine dynamics, and systemic coordination.
Over the years, Tesamorelin has become an important research peptide in studies of hormone signaling and molecular regulation.
Structure and Molecular Data of Tesamorelin
Peptide Name: Tesamorelin
Type of peptide: GHRH Analog
Sequence: Modified 44-amino acid peptide derived from GHRH
Molecular Formula: C₂₂₁H₃₆₆N₇₂O₆₇
Molecular Mass: ~5135.9 g/mol
Tesamorelin has a relatively large peptide structure designed for increased stability and effective receptor interaction, making it suitable for endocrine and molecular research.
Research findings of Tesamorelin
Tesamorelin has been studied extensively in endocrine and molecular models, with a focus on growth hormone signaling and regulation of biological pathways.
Key areas of research include:
- Interaction with GHRH receptors and signal transduction
- Growth hormone-related molecular signaling
- Regulation of the endocrine system and pathway dynamics
- Metabolic signaling and biochemical modulation
Main research domains
Endocrine research
Focus on growth hormone signaling and hormonal regulation.
Molecular research
Analysis of receptor binding and signaling pathway modulation.
Metabolic research
Study of interactions between hormones and metabolic systems.
Systemic research
Analysis of coordination within complex biological networks.
Scientific Relevance of Tesamorelin
Tesamorelin is considered an important GHRH-based research peptide, especially valuable for studying growth hormone signaling and endocrine interactions.
The targeted mechanism of action allows to analyze receptor-based signaling, hormonal communication, and pathway dynamics within controlled experimental systems.
Due to its specificity and structural design, Tesamorelin remains a relevant molecule within peptide research, molecular biology and endocrinology.
References
Teichman SL. et al. (2006). Effects of GHRH analogs on growth hormone signaling.
Veldhuis JD. et al. (2009). Regulation of growth hormone secretion dynamics.
Our Process
Frequently asked questions
Each batch is independently tested by third-party laboratories using HPLC and mass spectrometry. You can view the Certificate of Analysis (COA) of your specific batch on our lab results page.
Orders placed before 15:00 will be shipped the same day from our EU warehouse. Delivery typically takes 1–3 business days, depending on your location within Europe.